These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 30037284)
21. Prevalence Rates of Dementia and Mild Cognitive Impairment Are Affected by the Diagnostic Parameter Changes for Neurocognitive Disorders in the DSM-5 in a Korean Population. Han JW; So Y; Kim TH; Lee DY; Ryu SH; Kim SY; Kim SG; Kim SK; Youn JC; Jhoo JH; Kim JL; Lee SB; Lee JJ; Kwak KP; Moon SW; Kim BJ; Bae JN; Woo JI; Jeong H; Park JH; Kim YJ; Kim KW Dement Geriatr Cogn Disord; 2017; 43(3-4):193-203. PubMed ID: 28237992 [TBL] [Abstract][Full Text] [Related]
22. Neurobehavioral dysfunction in patients with subcortical vascular mild cognitive impairment and subcortical vascular dementia. Chin J; Seo SW; Kim SH; Park A; Ahn HJ; Lee BH; Kang SJ; Na DL Clin Neuropsychol; 2012; 26(2):224-38. PubMed ID: 22348292 [TBL] [Abstract][Full Text] [Related]
23. Poststroke apathy: Major role of cognitive, depressive and neurological disorders over imaging determinants. Aubignat M; Roussel M; Aarabi A; Lamy C; Andriuta D; Tasseel-Ponche S; Makki M; Godefroy O; Cortex; 2023 Mar; 160():55-66. PubMed ID: 36745966 [TBL] [Abstract][Full Text] [Related]
25. Neuropsychiatric symptoms are very common in premanifest and early stage Huntington's Disease. Martinez-Horta S; Perez-Perez J; van Duijn E; Fernandez-Bobadilla R; Carceller M; Pagonabarraga J; Pascual-Sedano B; Campolongo A; Ruiz-Idiago J; Sampedro F; Landwehrmeyer GB; ; Kulisevsky J Parkinsonism Relat Disord; 2016 Apr; 25():58-64. PubMed ID: 26898966 [TBL] [Abstract][Full Text] [Related]
26. Prevalence of neuropsychiatric symptoms in mild cognitive impairment and normal cognitive aging: population-based study. Geda YE; Roberts RO; Knopman DS; Petersen RC; Christianson TJ; Pankratz VS; Smith GE; Boeve BF; Ivnik RJ; Tangalos EG; Rocca WA Arch Gen Psychiatry; 2008 Oct; 65(10):1193-8. PubMed ID: 18838636 [TBL] [Abstract][Full Text] [Related]
27. [Neurocognitive and psychiatric management of the 22q11.2 deletion syndrome]. Demily C; Rossi M; Schneider M; Edery P; Leleu A; d'Amato T; Franck N; Eliez S Encephale; 2015 Jun; 41(3):266-73. PubMed ID: 25523123 [TBL] [Abstract][Full Text] [Related]
28. Vascular cognitive disorders and depression after first-ever stroke: the Fogarty-Mexico Stroke Cohort. Arauz A; Rodríguez-Agudelo Y; Sosa AL; Chávez M; Paz F; González M; Coral J; Díaz-Olavarrieta C; Román GC Cerebrovasc Dis; 2014; 38(4):284-9. PubMed ID: 25412708 [TBL] [Abstract][Full Text] [Related]
29. Neuropsychiatric predictors of conversion to dementia both in patients with amnestic mild cognitive impairment and those with subcortical vascular MCI. Kim SH; Kang HS; Kim HJ; Ryu HJ; Kim My; Seo SW; Na DL; Han SH Clin Neurol Neurosurg; 2013 Aug; 115(8):1264-70. PubMed ID: 23290121 [TBL] [Abstract][Full Text] [Related]
30. Unique effects of apathy and depression signs on cognition and function in amnestic mild cognitive impairment. Zahodne LB; Tremont G Int J Geriatr Psychiatry; 2013 Jan; 28(1):50-6. PubMed ID: 22368079 [TBL] [Abstract][Full Text] [Related]
31. Prevalence estimates of mild behavioral impairment in a population-based sample of pre-dementia states and cognitively healthy older adults. Mortby ME; Ismail Z; Anstey KJ Int Psychogeriatr; 2018 Feb; 30(2):221-232. PubMed ID: 28931446 [TBL] [Abstract][Full Text] [Related]
32. Neurocognitive clusters: A pilot study of young people with affective disorders in an inpatient facility. Tickell AM; Scott EM; Davenport T; Iorfino F; Ospina-Pinillos L; Harel K; Parker L; Hickie IB; Hermens DF J Affect Disord; 2019 Jan; 242():80-86. PubMed ID: 30172228 [TBL] [Abstract][Full Text] [Related]
33. Apathy in Mild Parkinson's Disease: Neuropsychological and Neuroimaging Evidence. Alzahrani H; Antonini A; Venneri A J Parkinsons Dis; 2016 Oct; 6(4):821-832. PubMed ID: 27567885 [TBL] [Abstract][Full Text] [Related]
34. Neuropsychiatric Symptoms are Related to Blood-biomarkers in Major Neurocognitive Disorders. Marques-Aleixo I; Sampaio A; Bohn L; Machado F; Barros D; Ribeiro O; Carvalho J; Magalhães J Curr Aging Sci; 2024; 17(1):74-84. PubMed ID: 37904566 [TBL] [Abstract][Full Text] [Related]
35. Characteristics of neurocognitive functions in mild cognitive impairment with depression. Dong HS; Han C; Jeon SW; Yoon S; Jeong HG; Huh YJ; Pae CU; Patkar AA; Steffens DC Int Psychogeriatr; 2016 Jul; 28(7):1181-90. PubMed ID: 26960534 [TBL] [Abstract][Full Text] [Related]
36. White matter microstructural damage and depressive symptoms in patients with mild cognitive impairment and cerebral small vessel disease: the VMCI-Tuscany Study. Pasi M; Poggesi A; Salvadori E; Diciotti S; Ciolli L; Del Bene A; Marini S; Nannucci S; Pescini F; Valenti R; Ginestroni A; Toschi N; Mascalchi M; Inzitari D; Pantoni L Int J Geriatr Psychiatry; 2016 Jun; 31(6):611-8. PubMed ID: 26489377 [TBL] [Abstract][Full Text] [Related]
37. Pharmacological management of neuropsychiatric symptoms in patients with major neurocognitive disorders. Elie D; Rej S J Psychiatry Neurosci; 2018 Jan; 43(1):69-70. PubMed ID: 29252167 [No Abstract] [Full Text] [Related]